Flecainide is well-tolerated and effective in patient with atrial fibrillation at 12 months: a retrospective study

INTRODUCTION: Current atrial fibrillation (AF) guidelines recommend flecainide as a first-line rhythm control option in patients without structural heart disease. While there is proven efficacy in clinical trials and guideline support, it is hypothesized that flecainide may be underutilized due to n...

Descripción completa

Detalles Bibliográficos
Autores principales: Muzzey, Mikayla, Tellor, Katie B., Ramaswamy, Karthik, Schwarze, Martin, Armbruster, Anastasia L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343357/
https://www.ncbi.nlm.nih.gov/pubmed/32633682
http://dx.doi.org/10.1177/1753944720926824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343357/
https://www.ncbi.nlm.nih.gov/pubmed/32633682
http://dx.doi.org/10.1177/1753944720926824

Ejemplares similares